By using this site, you agree to the Privacy Policy and Terms of Use.
Accept
Cannabis NewsCannabis News
  • Cannabis
  • CBD
  • Science
  • Culture & Arts
  • Cannabis Press Releases
  • More
    • About Maryjanes Post
    • Cannabis Advertising
    • Cannabis Partnerships
Reading: Global Cannabis Pharmaceuticals Market (2022 to 2028) – Size, Share & Trends Analysis Report – ResearchAndMarkets.com
Share
Aa
Aa
Cannabis NewsCannabis News
Search
  • Topics
    • Business
    • Cannabis
    • Cannabis Tech
    • Culture & Arts
    • Industry Leaders
    • Cannabis Press Releases
  • Topics
    • Business
    • Cannabis
    • Cannabis Tech
    • Culture & Arts
    • Industry Leaders
    • Cannabis Press Releases
  • About Maryjanes Post
    • Ambassador
    • Cannabis Partnerships
Follow US
  • Ad Choices
  • RSS Terms of Service
© 2018 - 2022 MaryJanes Post Media. All Rights Reserved.
Cannabis News > Cannabis Press Releases > Global Cannabis Pharmaceuticals Market (2022 to 2028) – Size, Share & Trends Analysis Report – ResearchAndMarkets.com
Cannabis Press Releases

Global Cannabis Pharmaceuticals Market (2022 to 2028) – Size, Share & Trends Analysis Report – ResearchAndMarkets.com

Business Wire
Last updated: 2022/02/23 at 3:40 PM
Business Wire Published February 23, 2022
Share
SHARE

DUBLIN–(BUSINESS WIRE)–The “Cannabis Pharmaceuticals Market Size, Share & Trends Analysis Report by Brand Type (Sativex, Epidiolex), by Region (North America, Europe, Asia Pacific, Latin America, Middle East & Africa), and Segment Forecasts, 2022-2028” report has been added to ResearchAndMarkets.com’s offering.

logo Cannabis Media & PR

The global cannabis pharmaceuticals market size is expected to reach USD 127.1 billion by 2028. The market is expected to expand at a CAGR of 104.2% from 2022 to 2028.

Companies Mentioned

  • GW Pharmaceuticals
  • AbbVie Inc.
  • Valeant Pharmaceuticals
  • Insys Therapeutics, Inc.

Rapid growth in applications of cannabis for various indications including pain, inflammation, sleep disorders, anorexia, epilepsy, schizophrenia, and multiple sclerosis is estimated to drive market growth. There is a shift from cannabis herbal preparations to prescription drugs. Demand for processed, quantified, and packaged cannabis products is significantly increasing. Moreover, consumer, as well as regulatory acceptance of cannabis products, is increasing which in turn is positively impacting market growth.

Regulatory acceptance of cannabis products such as Sativex and Epidiolex are improving patient and physician perspectives on cannabis as these drugs are developed and regulated by the stringent process.

The increasing number of research and development activities and clinical trials for studying the therapeutic benefits of cannabis will drive the market growth during the forecast period. For instance, in September 2020, Tilray Inc. announced that its cannabis products are showing promising results in reducing vomiting and nausea in patients undergoing chemotherapy for cancer. According to the study, a quarter of the patients consuming medical cannabis did not show nausea and vomiting. Such research studies are estimated to increase the demand for cannabis in the pharmaceutical industry.

There is a rise in a number of physicians prescribing cannabis to their patients due to increasing clinical evidence, growing awareness, and an increasing number of patients looking for cannabis as a medical alternative. For instance, according to a survey published in 2019, 22% of the consumers were looking for replacing prescription or OTC drugs with CBD. Moreover, 30% took CBD in addition to the prescribed drug. Forty-seven percent replaced an OTC drug with CBD, 36% with prescription opioids, 33% with prescription anxiety drugs, and 22% with prescription sleep drugs. Thus, increasing cannabis consumption will drive the pharmaceutical cannabis market globally.

Regulatory approval of cannabis is a major parameter supporting market growth. Governments and regulatory authorities are taking initiatives to legalize the use of cannabis for medical purposes. For instance, In August 2020, a regulatory authority in Portugal, INFARMED I.P., granted license to Clever Leaves for cultivation and import export of medical cannabis. For instance, in November 2018, GW Pharmaceuticals, plc launched EPIDIOLEX (CBD) oral solution for treating seizures associated with Lennox-Gastaut syndrome and Dravet syndrome. EPIDIOLEX was approved by the FDA in June 2018. It is the first prescription pharmaceutical formulation plant-derived CBD and an antiepileptic drug.

Cannabis Pharmaceuticals Market Report Highlights

  • The Epidiolex brand type emerged as the leading application segment in 2021, with a revenue share of 96.9% in the market
  • Europe dominated the market and accounted for the largest revenue share of 43.8% in 2021
  • In Middle East and Africa, the market is projected to expand at the fastest CAGR during the forecast period

Key Topics Covered:

Chapter 1 Methodology and Scope

Chapter 2 Executive Summary

Chapter 3 Global Cannabis Pharmaceuticals Market Variables, Trends, & Scope

3.1 Market Segmentation

3.2 Market Dynamics

3.2.1 Market Driver Analysis

3.2.2 Market Restraint Analysis

3.3 Penetration & Growth Prospects Mapping

3.4 Global Cannabis Pharmaceuticals Regulatory Scenario

3.5 Cannabis Pharmaceuticals – PESTEL Analysis

3.6 Cannabis Pharmaceuticals – Porter’s Analysis

3.7 Opportunity Analysis (2016 – 2019 – 2027)

3.8 Product Pipeline Analysis, By Stage

3.9 Key Deals and Strategic Alliances

3.10 Synthetic Cannabis Pharmaceuticals Overview

Chapter 4 Global Cannabis Pharmaceuticals Market: Brand Type Estimates & Trend Analysis

4.1 Definitions & Scope

4.2 Market: Brand Type Market Share Analysis, 2020 and 2028

4.3 Sativex

4.3.1 Market estimates and forecasts, 2016 – 2028 (USD Million)

4.4 Epidiolex

4.4.1 Market estimates and forecasts, 2016 – 2028 (USD Million)

Chapter 5 Global Cannabis Pharmaceuticals Market: Regional Estimates & Trend Analysis, By Brand Type, Deployment Model and End-user

Chapter 6 Global Cannabis Pharmaceuticals Market: Competitive Analysis

6.1 Company Market Position Analysis

6.2 List of Key Emerging Players and Market Differentiators

6.3 Company Categorization

6.4 Brand Share Analysis, 2018-2020

Chapter 7 Competitive Landscape

For more information about this report visit https://www.researchandmarkets.com/r/9ygo4x

Contacts

ResearchAndMarkets.com

Laura Wood, Senior Press Manager

press@researchandmarkets.com

For E.S.T Office Hours Call 1-917-300-0470

For U.S./CAN Toll Free Call 1-800-526-8630

For GMT Office Hours Call +353-1-416-8900

You Might Also Like

 Flower One Obtains Meeting Order Under the Companies’ Creditors Arrangement Act (Canada)

United States Alternative Adult Beverages Market Report 2022: The Burgeoning Adult Beverage Segment Expanding the Adult Beverage Horizon – ResearchAndMarkets.com

Global Cannabidiol Market Report 2022: Growing Acceptance and Use of Products Due to Government Approvals Drives Sector – ResearchAndMarkets.com

Organigram Launches HOLY MOUNTAIN to Further Support Its Strong Position in the Dried Flower and Hash Categories

Leafly to Participate at Upcoming Investor Conferences

TAGGED: Business Wire
Business Wire February 23, 2022
Share this Article
Twitter Reddit Email Copy Link
Previous Article MyMD Pharmaceuticals Enrolls First Patient in Phase 2 Clinical Trial of MYMD-1 as a Therapy for Delaying Aging and Extending Healthy Lifespan
Next Article Legal Cannabis Industry is the Most Prolific Job Creator in America – Supporting More Than 428,000 Jobs

Cannabis News and More

Work with an experienced cannabis media firm to provide your brand with the exposure it needs.

Cannabis Topics

  • Cannabis
  • Business
  • CBD
  • Cannabis Science
  • Culture & Arts

Company

  • About Maryjanes Post
  • Contact Cannabis Media
  • Contributor Guidelines

Terms of Use

  • TERMS
  • PRIVACY
  • CONTRIBUTOR AGREEMENT
  • DMCA

Resources

  • Write For UsNew
  • Media KitNew
  • Cannabis Advertising
  • Cannabis Partnerships
  • Cannabis Press ReleaseNew
Cannabis NewsCannabis News
Follow US

© 2018 - 2022 MaryJanes Post Media. All Rights Reserved.

  • Ad Choices
  • RSS Terms of Service
Go to mobile version
Welcome Back!

Sign in to your account

Lost your password?